Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting

View ORCID ProfileTereza Klučková, View ORCID ProfileMarek Nikolič, View ORCID ProfileFilip Tylš, View ORCID ProfileVojtěch Viktorin, View ORCID ProfileČestmír Vejmola, View ORCID ProfileMichaela Viktorinová, View ORCID ProfileAnna Bravermanová, Renáta Androvičová, View ORCID ProfileVeronika Andrashko, View ORCID ProfileJakub Korčák, Peter Zach, View ORCID ProfileKateřina Hájková, View ORCID ProfileMartin Kuchař, Marie Balíková, View ORCID ProfileMartin Brunovský, View ORCID ProfileJiří Horáček, View ORCID ProfileTomáš Páleníček
doi: https://doi.org/10.1101/2024.08.26.24311611
Tereza Klučková
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
2Third Faculty of Medicine, Charles University Prague, Ruská 87, 100 00 Praha 10, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tereza Klučková
Marek Nikolič
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
2Third Faculty of Medicine, Charles University Prague, Ruská 87, 100 00 Praha 10, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marek Nikolič
Filip Tylš
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
2Third Faculty of Medicine, Charles University Prague, Ruská 87, 100 00 Praha 10, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Filip Tylš
  • For correspondence: filip.r.tyls{at}gmail.com tomas.palenicek{at}nudz.cz
Vojtěch Viktorin
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
2Third Faculty of Medicine, Charles University Prague, Ruská 87, 100 00 Praha 10, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vojtěch Viktorin
Čestmír Vejmola
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
2Third Faculty of Medicine, Charles University Prague, Ruská 87, 100 00 Praha 10, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Čestmír Vejmola
Michaela Viktorinová
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
2Third Faculty of Medicine, Charles University Prague, Ruská 87, 100 00 Praha 10, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michaela Viktorinová
Anna Bravermanová
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
4First Faculty of Medicine, Charles University Prague, Kateřinská 32, 121 08 Prague 2, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Bravermanová
Renáta Androvičová
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronika Andrashko
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
2Third Faculty of Medicine, Charles University Prague, Ruská 87, 100 00 Praha 10, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Veronika Andrashko
Jakub Korčák
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jakub Korčák
Peter Zach
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kateřina Hájková
3Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague 6, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kateřina Hájková
Martin Kuchař
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
3Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague 6, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Kuchař
Marie Balíková
4First Faculty of Medicine, Charles University Prague, Kateřinská 32, 121 08 Prague 2, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Brunovský
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
2Third Faculty of Medicine, Charles University Prague, Ruská 87, 100 00 Praha 10, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Brunovský
Jiří Horáček
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
2Third Faculty of Medicine, Charles University Prague, Ruská 87, 100 00 Praha 10, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jiří Horáček
Tomáš Páleníček
1National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic
2Third Faculty of Medicine, Charles University Prague, Ruská 87, 100 00 Praha 10, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tomáš Páleníček
  • For correspondence: filip.r.tyls{at}gmail.com tomas.palenicek{at}nudz.cz
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Recent studies have intensively explored the potential antidepressant effects of psilocybin. However, important variables such as previous experience, repeated administration, setting and sex remain underexplored. This study describes the acute psilocybin experience and long-term effects in a small sample of healthy individuals.

Methods In a double-blind, placebo-controlled, cross-over study, 40 healthy participants (20 females, mean age 38, sd 8) received two doses of psilocybin 0.26 mg/kg per os at least 56 days apart (mean 354 days) in two study arms (EEG and fMRI). Near half of participants had experience with psychedelics. The Altered State of Consciousness Scale (ASC) and a visual analogue scale (VAS) on emotional valence of the phenomenology assessed acute phenomenology. The Persisting Effects Questionnaire (PEQ) assessed long- term effects. Venous blood samples were taken to measure serum psilocin levels.

Results All results were independent of previous experience, sex, EEG or fMRI arm/setting. Acute psychedelic effects were of moderate intensity on ASC. The VAS showed mostly pleasant and fluctuating, and only one unpleasant only experience. All experiences resolved in a positive or neutral state at the end of the session. Psilocybin induced sustained positive effects on all domains of the PEQ, with negligible negative effects. Oceanic Boundlessness and Visual Restructuralization were associated with positive effects on PEQ. Contrary to expectations, Dread of Ego Dissolution, typically associated with fearful experiences, was not associated with PEQ negative outcomes. The type of experience (pleasant or mixed) did not correlate with the intensity or direction of the lasting effect; however, peak experiences culminating in a positive mood were associated with positive long- term effects.

Conclusion In our sample repeated administration of psilocybin to healthy volunteers, induces positive, lasting effects. This underscores the psychological safety of psilocybin in a laboratory setting and supports its repeated use in clinical trials. In particular, challenging or anxiety-provoking experiences in controlled environments did not lead to adverse long-term outcomes.

Clinical trial registration: EudraCT 2012-004579-37, https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-004579-37/CZ.

Competing Interest Statement

T.P., M.B., F.T. and J.H. declare to have shares in Psyon s.r.o.. T.P., M.B., F.T. and J.H. founded the PSYRES-Psychedelic Research Foundation and have shares in Spolecnost pro podporu neurovedniho vyzkumu s.r.o.. T.P. reports consulting fees from GH Research and CB21-Pharma outside the submitted work. T.P., V.V., M.V. and F.T. are involved in Compass Pathways and/or MAPS clinical trial with psilocybin/MDMA trials outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Clinical Trial

EudraCT 2012-004579-37

Funding Statement

This work was supported by grant from Czech Health Research Council (project NU21- 04-00307), Czech Science Foundation (projects 20-25349S), Ministry of the interior of the Czech Republic (project VK01010212), Long-term conceptual development of research organization (RVO 00023752), and Specific University Research, Czech Ministry of Education, Youth and Sports (project 260648/SVV/2024), ERDF-Project Brain dynamics, No. CZ.02.01.01/00/22_008/0004643, project VVI CZECRIN (LM2023049) and Charles University research program Cooperatio-Neurosciences and private funds obtained via PSYRES, Psychedelic Research Foundation (https://psyresfoundation.eu).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee of National Institue of Mental Health, Topolova 648, 25067 Klecany, Czech Republic gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted August 26, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting
Tereza Klučková, Marek Nikolič, Filip Tylš, Vojtěch Viktorin, Čestmír Vejmola, Michaela Viktorinová, Anna Bravermanová, Renáta Androvičová, Veronika Andrashko, Jakub Korčák, Peter Zach, Kateřina Hájková, Martin Kuchař, Marie Balíková, Martin Brunovský, Jiří Horáček, Tomáš Páleníček
medRxiv 2024.08.26.24311611; doi: https://doi.org/10.1101/2024.08.26.24311611
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting
Tereza Klučková, Marek Nikolič, Filip Tylš, Vojtěch Viktorin, Čestmír Vejmola, Michaela Viktorinová, Anna Bravermanová, Renáta Androvičová, Veronika Andrashko, Jakub Korčák, Peter Zach, Kateřina Hájková, Martin Kuchař, Marie Balíková, Martin Brunovský, Jiří Horáček, Tomáš Páleníček
medRxiv 2024.08.26.24311611; doi: https://doi.org/10.1101/2024.08.26.24311611

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)